Get all your news in one place.
100's of premium titles.
One app.
Start reading
WEKU
WEKU
Sydney Lupkin

Drugmakers are slow to prove medicines that got a fast track to market really work

Kristi Alcayaga's teenage son, Michael, was able to try a cancer drug called clofarabine that got an accelerated approval from the Food and Drug Administration. But the medicine didn't help him. (Jovelle Tamayo for NPR)

Doctors told Kristi Alcayaga it was time to bring out the "big gun" to fight her teenage son's leukemia. She expected the chemotherapy he was prescribed to be blue. Or red. Or some sinister color to convey its toxicity.

Instead, the drug called Clolar looked just like water.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.